NOV 08, 2019 8:00 AM PST

Polygenic Risk Score analysis for Alzheimer's disease risk

Speaker
  • CEO, Cytox Ltd
    Biography
      Richard Pither has been involved in the development of diagnostic and therapeutic pharmaceutical products for more than 25 years. He has been CEO at Cytox for the past 7 years, a precision medicine working on developing and commercialising a new diagnostic technology for assessing Alzheimer's Disease risk. Prior to Cytox, Richard has held senior R&D and leadership positions in global pharmaceutical companies including GE Healthcare/Amersham plc, Lorantis and UCB-Celltech. During this time, he was involved in the development of a novel 18F-PET radiopharmaceutical for imaging amyloid deposition in the brains of Alzheimer's disease patients.

    Abstract
    DATE:  November 8, 2019
    TIME:  8:00am PT, 11:00am ET
     
    The utility of Polygenic Risk Scores (PRS) is gaining researchers' attention for identifying individual genetic risk and disease risk prediction in Alzheimer's Disease (AD) at both the early and pre-symptomatic stages of the disease. genoSCORE™ combines Cytox's proprietary technologies variaTECT™, a proprietary single nucleotide polymorphism (SNP) profiling array built on the Axiom platform from Thermo Fisher Scientific, with the SNPfitR™ analytical and interpretive software incorporating algorithms developed in partnership with Cardiff University, to give a PRS that identifies any individual's genetic risk of developing AD from blood or saliva-extracted DNA. This can help in patient stratification for clinical trial research to develop targeted treatments for AD.
     
    Learning Objectives:
    • Select the highest risk APOE3/E4 subjects mostly likely to develop AD
    • Identify highest/low risk APOE3/E3 subjects for inclusion/exclusion in clinical studies
     
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    DEC 16, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 16, 2020 8:00 AM PST
    Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
    APR 01, 2021 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 08, 2019 8:00 AM PST

    Polygenic Risk Score analysis for Alzheimer's disease risk


    Specialty

    Genetics

    Molecular Biology

    Genomics

    Molecular Diagnostics

    Clinical Diagnostics

    Cancer Research

    Laboratory Testing

    Clinical Research

    Biomarkers

    Biotechnology

    Immunology

    Cell Biology

    Gene Expression

    Dna

    Biochemistry

    Geography

    North America65%

    Europe17%

    Asia11%

    South America3%

    Oceania2%

    Africa2%

    Registration Source

    Email Promotions38%

    Website Visitors35%

    WAVE Newsletter Promotion4%

    Client/Sponsor Promotions2%

    Social Media Promotions1%

    Trending Newsletter Promotion1%

    Other19%

    Job Title

    Educator/Faculty15%

    Research Scientist13%

    Executive12%

    Medical Laboratory Technician10%

    Student8%

    Clinical Laboratory Scientist7%

    Lab Management7%

    Medical Doctor/Specialist6%

    Scientist6%

    Facility/Department Manager6%

    Post Doc4%

    Consultant2%

    Pathologist1%

    QC/QA1%

    Chemist1%

    Biologist1%

    Organization

    Academic Institution29%

    Clinical Laboratory15%

    Hospital12%

    Biotech Company7%

    Research Institute4%

    Medical School4%

    Consultant3%

    Medical Center3%

    Government2%

    Life Science Company2%

    Pharmaceutical Company2%

    Medical Device Company2%

    Diagnostic Company2%

    Non-Profit Organization2%

    Other4%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more